Atle Fund Management AB Diversified Active

Location: Stockholm, Sweden

CIK: 0001381843 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: Apr 28, 2017

Total Value: $65.21M (100.0% shares, 0.0% debt)

Holdings (10)

— AETNA INC NEW 17.4%

Value $11.35M Shares 89,000 Est. Cost $127.55 Unrealized —

COR AMERISOURCEBERGEN CORP 17.1%

Value $11.15M Shares 126,000 Est. Cost $61.79 Unrealized +7.6%

GILD GILEAD SCIENCES INC 12.2%

Value $7.947M Shares 117,000 Est. Cost $53.11 Unrealized -4.6%

ANIK ANIKA THERAPEUTICS INC 12.1%

Value $7.888M Shares 181,573 Est. Cost $38.78 Unrealized +23.1%

CRL CHARLES RIV LABS INTL INC 11.8%

Value $7.701M Shares 85,612 Est. Cost $63.72 Unrealized +33.3%

MCK MCKESSON CORP 11.6%

Value $7.561M Shares 51,000 Est. Cost $136.84 Unrealized -0.2%

— OSIRIS THERAPEUTICS INC NEW 8.4%

Value $5.473M Shares 1,140,222 Est. Cost $4.80 Unrealized —

— GNC HLDGS INC 4.8%

Value $3.113M Shares 422,955 Est. Cost $30.08 Unrealized —

— ACHILLION PHARMACEUTICALS IN 3.2%

Value $2.096M Shares 497,807 Est. Cost $4.21 Unrealized —

ICCC IMMUCELL CORP 1.4%

Value $931K Shares 168,323 Est. Cost $5.29 Unrealized +8.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	AETNA INC NEW	89,000	$11.35M	17.4%	$127.55	—	COM	00817Y108
COR	AMERISOURCEBERGEN CORP	126,000	$11.15M	17.1%	$61.79	+7.6%	COM	03073E105
GILD	GILEAD SCIENCES INC	117,000	$7.947M	12.2%	$53.11	-4.6%	COM	375558103
ANIK	ANIKA THERAPEUTICS INC	181,573	$7.888M	12.1%	$38.78	+23.1%	COM	035255108
CRL	CHARLES RIV LABS INTL INC	85,612	$7.701M	11.8%	$63.72	+33.3%	COM	159864107
MCK	MCKESSON CORP	51,000	$7.561M	11.6%	$136.84	-0.2%	COM	58155Q103
—	OSIRIS THERAPEUTICS INC NEW	1,140,222	$5.473M	8.4%	$4.80	—	COM	68827R108
—	GNC HLDGS INC	422,955	$3.113M	4.8%	$30.08	—	COM CL A	36191G107
—	ACHILLION PHARMACEUTICALS IN	497,807	$2.096M	3.2%	$4.21	—	COM	00448Q201
ICCC	IMMUCELL CORP	168,323	$931K	1.4%	$5.29	+8.6%	COM PAR $0.10	452525306